Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Mu-opioid receptor agonists
Dioxaphetyl butyrate
Другие языки:

Dioxaphetyl butyrate

Подписчиков: 0, рейтинг: 0
Dioxaphetyl butyrate
Spasmoxal.svg
Clinical data
Other names Amidalgon, Spasmoxal
Routes of
administration		 Oral, Other ROA Unknown
ATC code
  • none
Legal status
Legal status
Identifiers
  • Ethyl 4-morpholin-4-yl-2,2-di(phenyl)butanoate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard 100.006.731
Chemical and physical data
Formula C22H27NO3
Molar mass 353.462 g·mol−1
3D model (JSmol)
  • CCOC(=O)C(CCN1CCOCC1)(c1ccccc1)c1ccccc1
  • InChI=1S/C22H27NO3/c1-2-26-21(24)22(19-9-5-3-6-10-19,20-11-7-4-8-12-20)13-14-23-15-17-25-18-16-23/h3-12H,2,13-18H2,1H3 ☒N
  • Key:LQGIXNQCOXNCRP-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Dioxaphetyl butyrate (INN; trade names Amidalgon, Spasmoxal) is an opioid analgesic which is a diphenylacetic acid derivative, related to other open-chain opioid drugs such as dextropropoxyphene, levacetylmethadol (LAAM), lefetamine and dimenoxadol.

It produces similar effects to other opioids, including dependence, euphoria, analgesia, sedation, constipation, dizziness and nausea.

In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9621 and a 2013 annual aggregate manufacturing quota of zero.



Новое сообщение